Macquarie Group’s Tectonic Therapeutic TECX Stock Holding History

Macquarie Group’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-67	Closed	-$4K	–	2652
2021 Q3	$4K	Hold	67	–	–	﹤0.01%	2606
2021 Q2	$7K	Hold	67	–	–	﹤0.01%	2508
2021 Q1	$10K	Sell	67 -21	-24%	-$3.42K	﹤0.01%	2395
2020 Q4	$15K	Hold	88	–	–	﹤0.01%	2268
2020 Q3	$14K	Hold	88	–	–	﹤0.01%	2233
2020 Q2	$18K	Buy	+88	New	+$18.1K	﹤0.01%	2202

Other funds holding TECX

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Macquarie Group's TECX Position: Q4 2021 in Review

Macquarie Group sold out of Tectonic Therapeutic (TECX) in Q4 2021, closing a stake of 67 shares — an estimated $4K sold.

Macquarie Group first reported a position in TECX in Q2 2020 and held it in 6 quarters. The position peaked at $18K in Q2 2020. 92 funds tracked by Wall St. Rank hold TECX as of Q4 2021.

Macquarie Group reported no remaining Tectonic Therapeutic position as of Q4 2021 after selling out during the quarter.
Macquarie Group sold 67 Tectonic Therapeutic shares in Q4 2021, an estimated $4K.
Macquarie Group first reported a position in Tectonic Therapeutic in Q2 2020 and held it in 6 quarters.
Macquarie Group's Tectonic Therapeutic position peaked at $18K in Q2 2020.
92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2021.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.